The MTHFR 677C>T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis

Carcinogenesis

Volumn 25, Issue 8, 2004, Pages 1443-1448

  Saffroy, Raphaël ^a   Pham, Patrick ^a   Chiappini, Franck ^a,b   Gross Goupil, Marine ^a   Castera, Laurent ^a   Azoulay, Daniel ^a,c   Barrier, Alain ^d   Samuel, Didier ^c   Debuire, Brigitte ^a   Lemoine, Antoinette ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b PFIZER INC   (United States)

^c Centre Hépato Biliaire   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); THREONINE; DNA; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD);

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; BIOSYNTHESIS; DNA METHYLATION; FIBROSIS; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; LIVER; LIVER TUMOR; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DNA; DNA METHYLATION; FEMALE; FIBROSIS; GENOTYPE; HETEROZYGOTE; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+); MIDDLE AGED; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 4344703254     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh147     Document Type: Article

References (37)

1. Parkin,D.M., Pisani,P. and Ferlay,J. (1999) Global cancer statistics. CA Cancer J. Clin., 49, 33-64.
2. Niederau,C., Fischer,R., Sonnenberg,A., Stremmel,W., Trampisch,H.J. and Strohmeyer,G. (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med., 313, 1256-1262.
3. Eriksson,S., Carlson,J. and Velez,R. (1986) Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N. Engl. J. Med., 314, 736-739.
4. Chen,C.J., Yu,M.W. and Liaw,Y.F. (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol., 12, S294-308.
5. Wong,N., Lai,P., Pang,E. et al. (2000) Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin. Cancer Res., 6, 4000-4009.
6. Nishimura,T., Nishida,N., Itoh,T., Kuno,M., Minata,M., Komeda,T., Fukuda,Y., Ikai,I., Yamaoka,Y. and Nakao,K. (2002) Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss. Genes Chromosomes Cancer, 35, 329-339.
7. Yu,M.W., Gladek-Yarborough,A., Chiamprasert,S., Santella,R.M., Liaw,Y.F. and Chen,C.J. (1995) Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-1273.
8. Lee,H.S., Yoon,J.H., Kamimura,S., Iwata,K., Watanabe,H. and Kim,C.Y. (1997) Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. Int. J. Cancer, 71, 737-740.
9. Yu,M.W., Chiu,Y.H., Yang,S.Y., Santella,R.M., Chern,H.D., Liaw,Y.F. and Chen,C.J. (1999) Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br. J. Cancer, 80, 598-603.
10. Yu,M.W., Chiu,Y.H., Chiang,Y.C., Chen,C.H., Lee,T.H., Santella,R.M., Chern,H.D., Liaw,Y.F. and Chen,C.J. (1999) Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms and risk of hepatocellular carcinoma: independent and interactive effects. Am. J. Epidemiol., 149, 621-629.
11. Chau,T.K., Marakami,S., Kawai,B., Nasu,K., Kubota,T. and Ohnishi,A. (2000) Genotype analysis of the CYP2C19 gene in HCV-seropositive patients with cirrhosis and hepatocellular carcinoma, Life Sci., 67, 1719-1724.
12. Vogel,A., Kneip,S., Barut,A., Ehmer,U., Tukey,R.H., Manns,M.P. and Strassburg,C.P. (2001) Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology, 121, 1136-1144.
13. Yu,M.W., Yang,S.Y., Chiu,Y.H., Chiang,Y.C., Liaw,Y.F. and Chen,C.J. (1999) A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency and cigarette smoking in hepatitis B carriers. Hepatology, 29, 697-702.
14. Chen,J., Giovannucci,E., Kelsey,K., Rimm,E.B., Stampfer,M.J., Colditz,G.A., Spiegelman,D., Willett,W.C. and Hunter,D.J. (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res., 56, 4862-4864.
15. Ma,J., Stampfer,M.J., Giovannucci,E., Artigas,C., Hunter,D.J., Fuchs,C., Willett,W.C., Selhub,J., Hennekens,C.H. and Rozen,R. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res., 57, 1098-1102.
16. Slattery,M.L., Potter,J.D., Samowitz,W., Schaffer,D. and Leppert,M. (1999) Methylenetetrahydrofolate reductase, diet and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev., 8, 513-518.
17. Skibola,C.F., Smith,M.T., Kane,E., Roman,E., Rollinson,S., Cartwright,R.A. and Morgan,G. (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl Acad. Sci. USA, 96, 12810-12815.
18. Franco,R.F., Simoes,B.P., Tone,L.G., Gabellini,S.M., Zago,M.A. and Falcao,R.P. (2001) The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br. J. Haematol., 115, 616-618.
19. Esteller,M., Garcia,A., Martinez-Palones,J.M., Xercavins,J. and Reventos,J. (1997) Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis, 18, 2307-2311.
20. Song,C., Xing,D., Tan,W., Wei,Q. and Lin,D. (2001) Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res., 61, 3272-3275.
21. Chen,J., Ma,J., Stampfer,M.J., Palomeque,C., Selhub,J. and Hunter,D.J. (2002) Linkage disequilibrium between the 667C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenomics, 12, 339-342.
22. Giovannucci,E., Chen,J., Smith-Warner,S.A., Rimm,E.B., Fuchs,C.S., Palomeque,C., Willett,W.C. and Hunter,D.J. (2003) Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet and risk of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 12, 970-979.
23. Frosst,P., Blom,H.J., Milos,R. et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet., 10, 111-113.
24. Ferre,N., Gomez,F., Camps,J., Simo,J.M., Murphy,M.M., Fernandez-Ballart,J. and Joven,J. (2002) Plasma homocysteine concentrations in patients with liver cirrhosis. Clin. Chem., 48, 183-185.
25. Choi,S.W. and Mason,J.B. (2000) Folate and carcinogenesis: an integrated scheme. J. Nutr., 130, 129-132.
26. Seitz,H.K., Poschl,G. and Simanowski,U.A. (1998) Alcohol and cancer. Recent Dev. Alcohol, 14, 67-95.
27. Giovannucci,E., Rimm,E.B., Ascherio,A., Stampfer,M.J., Colditz,G.A. and Willett,W.C. (1995) Alcohol, low-methionine - low-folate diets and risk of colon cancer in men. J. Natl Cancer Inst., 87, 265-273.
28. Saffroy,R., Lemoine,A., Haas,P., Marion,S. and Debuire,B. (2002) Rapid automated simultaneous screening of (G1691A) factor V, (G20210A) Prothrombin and (C677T) methylenetetrahydrofolate reductase variants by multiplex PCR using fluorescence scanning technology. Genet Test., 6, 233-236.
29. Bleich,S., Degner,D., Wiltfang,J. et al. (2000) Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol, 35, 351-354.
30. de la Vega,M.J., Santolaria,F., Gonzalez-Reimers,E., Aleman,M.R., Milena,A., Martinez-Riera,A. and Gonzalez-Garcia,C. (2001) High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR). Alcohol, 25, 59-67.
31. Machover,D., Zittoun,J., Saffroy,R. et al. (2002) Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis. Cancer Res., 62, 4685-4689.
32. Lin,C.H., Hsieh,S.Y., Sheen,I.S., Lee,W.C., Chen,T.C., Shyu,W.C. and Liaw,Y.F. (2001) Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res., 61, 4238-4243.
33. Blount,B.C., Mack,M.M., Wehr,C.M., MacGregor,J.T., Hiatt,R.A., Wang,G., Wickramasinghe,S.N., Everson,R.B. and Ames,B.N. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl Acad. Sci. USA, 94, 3290-3295.
34. Jacob,R.A., Gretz,D.M., Taylor,P.C., James,S.J., Pogribny,I.P., Miller,B.J., Henning,S.M. and Swendseid,M.E. (1998) Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr., 128, 1204-1212.
35. Dianov,G.L., Timchenko,T.V., Sinitsina,O.I., Kuzminov,A.V., Medvedev,O.A. and Salganik,R.I. (1991) Repair of uracil residues closely spaced on the opposite strands of plasmid DNA results in double-strand break and deletion formation. Mol. Gen. Genet., 225, 448-452.
36. Hagmar,L., Bonassi,S., Stromberg,U., Brogger,A., Knudsen,L.E., Norppa,H. and Reuterwall,C. (1998) Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res., 58, 4117-4121.
37. Bonassi,S., Hagmar,L., Stromberg,U. et al. (2000) Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res., 60, 1619-1625.